APA

Magnant J., Ohresser M., Allanore Y., de Monte M., Lafosse-Marin M., Degenne D., Guilmot J. L., Watier H. & Diot E. (20121121). Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study. : Rheumatology international.

Chicago

Magnant J, Ohresser M, Allanore Y, de Monte M, Lafosse-Marin M, Degenne D, Guilmot J L, Watier H and Diot E. 20121121. Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study. : Rheumatology international.

Harvard

Magnant J., Ohresser M., Allanore Y., de Monte M., Lafosse-Marin M., Degenne D., Guilmot J. L., Watier H. and Diot E. (20121121). Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study. : Rheumatology international.

MLA

Magnant J, Ohresser M, Allanore Y, de Monte M, Lafosse-Marin M, Degenne D, Guilmot J L, Watier H and Diot E. Association of Fcγ receptor IIIA variant with a subset of anti-topoisomerase I-positive patients in systemic sclerosis: a descriptive pilot study. : Rheumatology international. 20121121.